Matthias Miederer - Concepedia

Author

Matthias Miederer

Johannes Gutenberg University Mainz ORCID

Also Known As

Bernd Krause, C. Thomas, M Miederer, M. Miederer, Manuela A. Hoffmann, Matthias Miederer, Miederer Matthias, Miederer, Matthias, Simone Marnitz-Schulze

157

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz University Medical Center of the Johannes Gutenberg University Mainz Klinikum rechts der Isar Heidelberg University Technical University of Munich

About

Matthias Miederer is an author at Johannes Gutenberg University Mainz specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	2.4K
2	Engineering	4	4	705
3	Health Sciences	4	4	257
4	Natural Sciences	1	1	12
5	Allergy	1	1	13

Matthias Miederer

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma Uğur Şahin, Petra Oehm, Evelyna Derhovanessian, Nature Checkpoint-inhibitor-treated MelanomaMelanomaImmunologyTherapeutic VaccineCancer Vaccines	2020	961
Tumor Therapy with Targeted Atomic Nanogenerators Michael R. McDevitt, Dangshe Ma, Lawrence Lai, Science NanoparticlesNanomedicineDrug TargetingEngineeringTumor Therapy	2001	501
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy Kathrin Renner, Annette Schnell, Gudrun E. Koehl, Cell Reports	2019	286
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial Ursula Nestle, Tanja Schimek‐Jasch, Stephanie Kremp, The Lancet Oncology EngineeringOncologic ImagingMedical ImagingBiomedical ImagingMolecular Imaging	2020	169
Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT Matthias Miederer, Stefan Seidl, Andreas K. Buck, European Journal of Nuclear Medicine and Molecular Imaging Standardised Uptake ValuesMedicineImmunologyReceptor (Biochemistry)Pathology	2008	161
Preclinical Evaluation of the α-Particle Generator Nuclide 225Ac for Somatostatin Receptor Radiotherapy of Neuroendocrine Tumors Matthias Miederer, Gjermund Henriksen, Andrea Alke, Clinical Cancer Research	2008	151
Targeted actinium-225 in vivo generators for therapy of ovarian cancer. Paul E. Borchardt, Rui Yuan, Matthias Miederer, PubMed MedicineAlpha ParticlesImmunologyPharmacologyCancer Cell Biology	2003	150
GABAergic Dysfunction in Essential Tremor: An<sup>11</sup>C-Flumazenil PET Study Henning Boecker, A. Weindl, David J. Brooks, Journal of Nuclear Medicine	2010	137
DNA Double Strand Breaks as Predictor of Efficacy of the Alpha-Particle Emitter Ac-225 and the Electron Emitter Lu-177 for Somatostatin Receptor Targeted Radiotherapy Jörg Fahrer, Stephan Maus, Frank Bruchertseifer, PLoS ONE	2014	135
Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates. Matthias Miederer, Michael R. McDevitt, George Sgouros, PubMed	2004	120

Page 1